Illustration of Enterobacter aerogenes bacteria, magnified view under a microscope, a hospital setting in the background, and a red warning sign symbolizing the danger it poses.

Enterobacter aerogenes: A Hospital-Acquired Infection Concern

 2023-12-01
Share: TwitterFacebookPinterestLinkedin

Introduction to Enterobacter aerogenes

Enterobacter aerogenes, a member of the Enterobacteriaceae family, is a bacterial species that is increasingly recognized as a significant cause of hospital-acquired infections. This gram-negative bacterium is commonly found in the human gastrointestinal tract and other environmental sources. However, it is its role as a pathogen in healthcare settings that has drawn the attention of medical professionals and researchers.

Enterobacter aerogenes is capable of causing a wide range of infections, including urinary tract infections, respiratory tract infections, skin and soft tissue infections, and bloodstream infections. These infections can be particularly severe in individuals with weakened immune systems, such as those in intensive care units or undergoing invasive medical procedures.

One of the key concerns with Enterobacter aerogenes is its ability to rapidly develop resistance to multiple antibiotics, making infections difficult to treat. This resistance often leads to increased hospital stays, higher medical costs, and, in some cases, increased mortality rates. Therefore, understanding Enterobacter aerogenes, its transmission, and strategies for prevention and treatment is crucial to control its spread and impact in healthcare settings.

This article provides a comprehensive overview of Enterobacter aerogenes, covering its origin and spread, symptoms of infection, risk factors, diagnostic methods, treatment strategies, and prevention measures. We will also discuss the broader public health implications of this bacterium and future perspectives on managing Enterobacter aerogenes infections.

Table of contents

The Origin and Spread of Enterobacter aerogenes

Enterobacter aerogenes, a member of the Enterobacteriaceae family, is a gram-negative bacterium that can be found in various environments, including water, soil, and the human gut. However, it’s in the healthcare setting that this bacterium often becomes a significant concern. It’s known as a hospital-acquired or nosocomial infection, meaning it’s often contracted during hospital stays.

The bacterium can survive on various surfaces, from medical instruments to the hands of healthcare workers, making it easy to spread within a hospital environment. It’s typically transmitted through direct contact, either patient-to-patient or through contaminated surfaces. This ability to persist in both human hosts and environmental reservoirs has allowed it to spread in healthcare settings worldwide.

Over the years, Enterobacter aerogenes has demonstrated an alarming ability to acquire and spread resistance to multiple antibiotics, leading to an increase in hard-to-treat infections. This resistance is often due to the bacterium’s ability to produce beta-lactamases, enzymes that can break down many common antibiotics, rendering them ineffective. This has led to the bacterium being classified as a multi-drug resistant organism (MDRO).

Global surveillance studies have shown a rising trend of Enterobacter aerogenes infections, particularly in intensive care units (ICUs). This increase, along with the bacterium’s resistance to multiple antibiotics, has made it a significant concern in healthcare settings around the world.

Understanding the origin and spread of Enterobacter aerogenes is crucial to developing effective strategies to control its spread and treat infections caused by this bacterium. This involves ongoing research and surveillance, as well as the implementation of rigorous infection control measures in healthcare settings.

Symptoms of Enterobacter aerogenes Infections

Enterobacter aerogenes is a type of bacteria that can cause hospital-acquired infections. When this bacterium infects a patient, it can lead to a range of symptoms depending on the site of infection and the individual’s overall health.

Common symptoms of Enterobacter aerogenes infections include:

  • Fever: Patients with Enterobacter aerogenes infections often experience a high fever, which is the body’s natural response to fighting off the infection.
  • Respiratory symptoms: Infections in the respiratory tract can cause symptoms such as coughing, shortness of breath, chest pain, and sputum production.
  • Urinary tract symptoms: Enterobacter aerogenes infections in the urinary tract can lead to symptoms such as frequent urination, pain or burning during urination, cloudy or bloody urine, and pelvic discomfort.
  • Wound infections: If Enterobacter aerogenes infects a surgical wound or an open wound, symptoms may include redness, swelling, warmth, pain, and discharge from the wound.
  • Gastrointestinal symptoms: Infections in the gastrointestinal tract can cause symptoms such as diarrhea, abdominal pain, nausea, and vomiting.
  • Systemic symptoms: In severe cases, Enterobacter aerogenes infections can spread throughout the body, leading to symptoms such as fatigue, confusion, low blood pressure, and organ failure.

It is important to note that the severity and specific symptoms of Enterobacter aerogenes infections can vary from person to person. Some individuals may only experience mild symptoms, while others may develop more severe complications.

If you suspect that you or a loved one may have an Enterobacter aerogenes infection, it is crucial to seek medical attention promptly. A healthcare professional will be able to evaluate your symptoms, perform diagnostic tests, and recommend the appropriate treatment.

Risk Factors for Acquiring Enterobacter aerogenes

Enterobacter aerogenes is a type of bacteria that is commonly found in hospitals and healthcare settings. While it is a normal part of the human gut flora and does not typically cause harm in healthy individuals, it can pose a significant risk to those with weakened immune systems or who are hospitalized for extended periods. Understanding the risk factors for acquiring Enterobacter aerogenes infections is crucial in preventing its spread and ensuring patient safety.

One of the primary risk factors for acquiring Enterobacter aerogenes is prolonged hospitalization. When patients are admitted to hospitals, they are often exposed to a variety of bacteria, including Enterobacter aerogenes, due to the close proximity of other patients, healthcare workers, and medical equipment. The longer a patient stays in the hospital, the higher the risk of acquiring an infection.

Another significant risk factor is the use of invasive medical devices. Enterobacter aerogenes can colonize on medical devices such as urinary catheters, ventilators, and intravenous lines. These devices provide a direct pathway for the bacteria to enter the body and cause infection. Patients who require these devices for an extended period are at a higher risk of developing Enterobacter aerogenes infections.

Patients with compromised immune systems are also more susceptible to Enterobacter aerogenes infections. This includes individuals with conditions such as HIV/AIDS, cancer, or those undergoing immunosuppressive therapy. A weakened immune system makes it more difficult for the body to fight off infections, increasing the likelihood of acquiring Enterobacter aerogenes.

Poor hand hygiene practices among healthcare workers can contribute to the spread of Enterobacter aerogenes. If healthcare providers do not properly wash their hands or sanitize them between patient interactions, they can inadvertently transfer the bacteria from one patient to another. This highlights the importance of strict adherence to hand hygiene protocols in healthcare settings.

Overuse or misuse of antibiotics is another risk factor for Enterobacter aerogenes infections. The widespread use of broad-spectrum antibiotics can lead to the development of antibiotic-resistant strains of Enterobacter aerogenes. When these resistant strains emerge, they become more difficult to treat, posing a greater risk to patients.

Individuals who have undergone recent surgeries, particularly abdominal or gastrointestinal surgeries, are also at an increased risk of acquiring Enterobacter aerogenes infections. Surgical wounds provide an entry point for bacteria, and the disruption of normal bodily functions during surgery can weaken the immune system, making it harder to fight off infections.

Lastly, overcrowding and poor infection control practices in hospitals can contribute to the spread of Enterobacter aerogenes. When healthcare facilities are understaffed or lack proper protocols for preventing infections, it becomes more challenging to contain and prevent the transmission of bacteria.

It is important for healthcare providers and patients to be aware of these risk factors and take appropriate measures to minimize the risk of acquiring Enterobacter aerogenes infections. By implementing strict infection control practices, promoting proper hand hygiene, and judiciously using antibiotics, the spread of Enterobacter aerogenes can be mitigated, ensuring the safety and well-being of patients in healthcare settings.

Diagnostic Methods for Enterobacter aerogenes

Diagnosing Enterobacter aerogenes infections can be a complex process that requires careful consideration of various factors. Healthcare professionals employ several diagnostic methods to identify and confirm the presence of Enterobacter aerogenes in patients. These methods help in determining the appropriate treatment plan and preventing the spread of the infection.

One of the primary diagnostic methods for Enterobacter aerogenes infections is obtaining a patient’s medical history and conducting a physical examination. This initial assessment helps healthcare providers identify any potential risk factors or symptoms associated with the infection. Patients who have been hospitalized or have undergone invasive procedures are at a higher risk of acquiring Enterobacter aerogenes, and their medical history can provide valuable insights.

In addition to the medical history, laboratory tests play a crucial role in diagnosing Enterobacter aerogenes infections. The most common laboratory test is a culture and sensitivity test, which involves collecting a sample from the site of infection. This could include blood, urine, sputum, or wound samples.

The collected sample is then sent to a laboratory where it is cultured on specific growth media that promote the growth of Enterobacter aerogenes. The culture is observed for any visible signs of bacterial growth, such as colonies. Once the bacteria have grown, they can be further analyzed to confirm their identity as Enterobacter aerogenes.

Identification of Enterobacter aerogenes is typically done using various biochemical tests. These tests assess the metabolic characteristics of the bacteria, such as their ability to ferment certain sugars or produce specific enzymes. The results of these tests help differentiate Enterobacter aerogenes from other similar bacteria.

In recent years, molecular diagnostic methods have also become increasingly important in identifying Enterobacter aerogenes infections. Polymerase chain reaction (PCR) is a commonly used molecular technique that detects the genetic material of the bacteria. PCR can provide rapid and accurate results, allowing for timely diagnosis and appropriate treatment.

Once the presence of Enterobacter aerogenes is confirmed, it is essential to determine the antibiotic susceptibility of the bacteria. This is done through antibiotic susceptibility testing, where the isolated bacteria are exposed to different antibiotics to assess their effectiveness. The results of this testing guide healthcare providers in selecting the most appropriate antibiotic for treatment.

It is important to note that accurate and timely diagnosis of Enterobacter aerogenes infections is crucial for effective management and prevention of further spread. Healthcare professionals should follow proper infection control protocols and work closely with laboratory personnel to ensure accurate testing and interpretation of results.

Treatment Strategies for Enterobacter aerogenes Infections

When it comes to treating Enterobacter aerogenes infections, a multifaceted approach is necessary due to the potential for antibiotic resistance and the severity of the infections it can cause. The choice of treatment depends on several factors, including the site and severity of the infection, the patient’s overall health, and the susceptibility of the specific strain of Enterobacter aerogenes to different antibiotics.

1. Antibiotic Therapy:

Antibiotics are the primary treatment for Enterobacter aerogenes infections. However, due to the increasing prevalence of antibiotic resistance, it is crucial to determine the susceptibility of the specific strain causing the infection. This is typically done through laboratory testing, such as susceptibility testing or genetic analysis.

The choice of antibiotics may include:

  • Beta-lactam antibiotics: These include penicillins, cephalosporins, and carbapenems. However, Enterobacter aerogenes strains producing extended-spectrum beta-lactamases (ESBLs) or carbapenemases may be resistant to these antibiotics.
  • Fluoroquinolones: These antibiotics are effective against many Enterobacter aerogenes strains, but resistance can develop.
  • Aminoglycosides: These antibiotics are often used in combination with beta-lactam antibiotics to enhance their effectiveness.
  • Other antibiotics: In some cases, alternative antibiotics such as tigecycline or polymyxins may be used if the strain is resistant to other options.

It is important to note that the choice of antibiotics should be based on the susceptibility testing results and guided by the recommendations of infectious disease specialists.

2. Supportive Care:

In addition to antibiotic therapy, supportive care plays a crucial role in the treatment of Enterobacter aerogenes infections. This may include:

  • Fluid and electrolyte replacement to maintain hydration and balance.
  • Pain management.
  • Respiratory support for patients with severe respiratory infections.
  • Wound care for patients with surgical site infections.

3. Infection Control Measures:

Preventing the spread of Enterobacter aerogenes infections within healthcare settings is essential. Strict infection control measures, such as proper hand hygiene, isolation precautions, and environmental cleaning, should be implemented to minimize the risk of transmission.

4. Addressing Antibiotic Resistance:

Given the increasing prevalence of antibiotic resistance in Enterobacter aerogenes, it is crucial to address this challenge. This includes:

  • Implementing antibiotic stewardship programs to promote appropriate antibiotic use.
  • Developing new antibiotics or alternative treatment options.
  • Continued surveillance of antibiotic resistance patterns to guide treatment decisions.
  • Education and awareness campaigns for healthcare professionals and the general public regarding the proper use of antibiotics.

5. Follow-up and Monitoring:

Patients with Enterobacter aerogenes infections should be closely monitored to evaluate the response to treatment and to identify any potential complications. Regular follow-up visits and appropriate laboratory tests may be necessary to ensure the infection is effectively controlled.

The Challenge of Antibiotic Resistance

Antibiotic resistance is a significant challenge when it comes to treating Enterobacter aerogenes infections. Enterobacter aerogenes, like many other bacteria, has the ability to develop resistance to antibiotics over time. This resistance can occur through various mechanisms, including genetic mutations or the acquisition of resistance genes from other bacteria.

The overuse and misuse of antibiotics in both human medicine and agriculture have contributed to the emergence and spread of antibiotic-resistant bacteria, including Enterobacter aerogenes. When antibiotics are used improperly or unnecessarily, bacteria have more opportunities to develop resistance. This can happen when a course of antibiotics is not completed, allowing some bacteria to survive and potentially develop resistance.

Enterobacter aerogenes has been found to be resistant to a wide range of antibiotics, including penicillins, cephalosporins, and fluoroquinolones. This makes it challenging for healthcare professionals to effectively treat infections caused by this bacterium. In some cases, Enterobacter aerogenes infections may require the use of multiple antibiotics or combination therapies to achieve successful treatment.

Furthermore, the problem of antibiotic resistance is not limited to Enterobacter aerogenes alone. It is a global concern that affects the treatment of various bacterial infections. The World Health Organization (WHO) has identified antibiotic resistance as one of the biggest threats to global health, as it can lead to longer hospital stays, increased healthcare costs, and higher mortality rates.

To address the challenge of antibiotic resistance, healthcare professionals must prioritize the appropriate and responsible use of antibiotics. This includes prescribing antibiotics only when necessary, adhering to proper dosing regimens, and promoting infection prevention measures to reduce the spread of bacteria.

Additionally, research and development of new antibiotics and alternative treatment options are crucial in combating antibiotic resistance. Scientists are continuously working to discover and develop novel antimicrobial agents that can effectively target and eliminate antibiotic-resistant bacteria like Enterobacter aerogenes.

In conclusion, antibiotic resistance poses a significant challenge in the treatment of Enterobacter aerogenes infections. It is essential to implement strategies to prevent the emergence and spread of antibiotic resistance, as well as to invest in the development of new treatment options. By addressing this challenge, we can improve patient outcomes and safeguard public health.

Prevention Strategies for Enterobacter aerogenes

Prevention Strategies for Enterobacter aerogenes are crucial in reducing the spread of this hospital-acquired infection. By implementing effective preventive measures, healthcare facilities can significantly minimize the risk of Enterobacter aerogenes infections among patients, healthcare workers, and visitors.

Here are some key prevention strategies that can be employed:

  1. Infection Control Measures: Strict adherence to infection control protocols is essential in preventing the transmission of Enterobacter aerogenes. This includes proper hand hygiene practices, such as frequent handwashing with soap and water or using alcohol-based hand sanitizers. Healthcare workers should also wear appropriate personal protective equipment (PPE), such as gloves and gowns, when in contact with patients.
  2. Cleaning and Disinfection: Regular and thorough cleaning of healthcare facilities is crucial in eliminating Enterobacter aerogenes and other pathogens. Surfaces, medical equipment, and patient care items should be properly disinfected using recommended disinfectants. Special attention should be given to high-touch surfaces, such as doorknobs, bedrails, and light switches.
  3. Antibiotic Stewardship: The overuse and misuse of antibiotics contribute to the development of antibiotic-resistant strains of Enterobacter aerogenes. Implementing antibiotic stewardship programs can help ensure appropriate prescribing and use of antibiotics, reducing the risk of antibiotic resistance. Healthcare providers should follow evidence-based guidelines when prescribing antibiotics and regularly review the need for continued therapy.
  4. Isolation Precautions: Patients infected or colonized with Enterobacter aerogenes should be placed on appropriate isolation precautions to prevent the spread of the infection. This may include placing the patient in a single room or cohorting patients with the same organism. Healthcare workers should strictly adhere to isolation protocols, including wearing appropriate PPE and following proper disinfection practices.
  5. Education and Training: Proper education and training of healthcare workers, patients, and visitors are essential in raising awareness about Enterobacter aerogenes and the importance of infection prevention. Healthcare facilities should provide regular training sessions on infection control practices, hand hygiene, and proper use of PPE. Patients and visitors should also be educated about their role in preventing the spread of infections.
  6. Surveillance and Monitoring: Regular surveillance and monitoring of Enterobacter aerogenes infections can help identify outbreaks and trends, enabling prompt intervention and control measures. Healthcare facilities should have robust surveillance systems in place to detect and respond to infections effectively.

By implementing these prevention strategies, healthcare facilities can reduce the risk of Enterobacter aerogenes infections and protect the health and well-being of patients, healthcare workers, and the community at large.

Impact of Enterobacter aerogenes on Public Health

Enterobacter aerogenes is a bacterium that poses a significant concern for public health, particularly in the context of hospital-acquired infections. Its impact on public health is multifaceted and can have serious consequences for patients, healthcare providers, and the healthcare system as a whole.

One of the primary impacts of Enterobacter aerogenes on public health is its ability to cause infections that are difficult to treat. This bacterium is known for its ability to develop resistance to multiple antibiotics, making it challenging to find effective treatment options. This can lead to prolonged hospital stays, increased healthcare costs, and higher morbidity and mortality rates among infected patients.

The spread of Enterobacter aerogenes within healthcare settings is another significant concern. Due to its ability to survive on surfaces and equipment, it can easily be transmitted from patient to patient, healthcare worker to patient, or through contaminated medical devices. This can result in outbreaks within hospitals, leading to increased healthcare-associated infections and the potential for the spread of antibiotic-resistant strains.

Furthermore, Enterobacter aerogenes infections can have a detrimental impact on patient outcomes. Infections caused by this bacterium can lead to severe complications, such as pneumonia, bloodstream infections, urinary tract infections, and surgical site infections. These complications can prolong hospital stays, require additional medical interventions, and increase the risk of long-term health problems for patients.

The impact of Enterobacter aerogenes on public health extends beyond the individual patient level. Outbreaks caused by this bacterium can strain healthcare resources, including personnel, equipment, and financial resources. The need for additional infection control measures, such as enhanced cleaning protocols and isolation precautions, can further burden healthcare facilities and disrupt normal operations.

Additionally, the emergence of antibiotic-resistant Enterobacter aerogenes strains has broader implications for public health. The overuse and misuse of antibiotics have contributed to the development of resistance, not only in Enterobacter aerogenes but also in other bacteria. This threatens the effectiveness of antibiotics as a whole and can make treating infections more challenging, not only for Enterobacter aerogenes but for a wide range of bacterial pathogens.

In conclusion, Enterobacter aerogenes is a hospital-acquired infection concern that has a significant impact on public health. Its ability to cause difficult-to-treat infections, its potential for transmission within healthcare settings, and the emergence of antibiotic resistance all contribute to the challenges it poses. Effective infection control measures, appropriate antibiotic use, and ongoing research into prevention and treatment strategies are crucial to mitigating the impact of Enterobacter aerogenes on public health.

Future Perspectives on Enterobacter aerogenes

As we look towards the future, it is important to consider the potential impact of Enterobacter aerogenes and the measures that can be taken to address this hospital-acquired infection concern.

One of the key areas of focus is the development of new diagnostic methods for Enterobacter aerogenes. Rapid and accurate detection of this bacterium is crucial for early intervention and appropriate treatment. Researchers are exploring advanced molecular techniques, such as polymerase chain reaction (PCR), to quickly identify Enterobacter aerogenes strains and determine their antibiotic resistance profiles. These advancements in diagnostics will enable healthcare professionals to make informed decisions and tailor treatment regimens accordingly.

Another area of interest is the ongoing research on treatment strategies for Enterobacter aerogenes infections. As antibiotic resistance continues to be a challenge, scientists are investigating alternative therapies, such as phage therapy and antimicrobial peptides. Phage therapy involves using bacteriophages, which are viruses that specifically target and kill bacteria, including Enterobacter aerogenes. Antimicrobial peptides, on the other hand, are naturally occurring molecules that possess antimicrobial properties and can be used as potential therapeutic agents. These emerging treatment approaches show promise in combating Enterobacter aerogenes infections.

Furthermore, the development of novel antibiotics with activity against Enterobacter aerogenes is crucial. Pharmaceutical companies and researchers are working towards discovering new compounds that can effectively target this bacterium and overcome antibiotic resistance mechanisms. By expanding the arsenal of effective antibiotics, healthcare professionals will have more options for treating Enterobacter aerogenes infections and reducing the risk of complications.

In addition to these research efforts, prevention strategies play a vital role in mitigating the spread of Enterobacter aerogenes. Strict adherence to infection control practices, such as proper hand hygiene, disinfection of equipment, and isolation protocols, can significantly reduce the transmission of this bacterium within healthcare settings. Ongoing education and training for healthcare workers are essential to ensure compliance with these preventive measures.

Collaboration between healthcare facilities, researchers, and public health agencies is also crucial in addressing the impact of Enterobacter aerogenes on public health. Sharing data, best practices, and surveillance information can help identify outbreaks, track antibiotic resistance patterns, and implement targeted interventions. By working together, stakeholders can strengthen infection control measures and improve patient outcomes.

Looking ahead, it is important to recognize that the battle against Enterobacter aerogenes and other hospital-acquired infections is an ongoing one. Continued research, innovation, and collaboration are necessary to stay one step ahead of this bacterium and protect vulnerable patients.

Common Questions and Answers about Enterobacter aerogenes

Common Questions and Answers about Enterobacter aerogenes

As a hospital-acquired infection concern, Enterobacter aerogenes raises several questions in the minds of individuals. Here are some common queries about Enterobacter aerogenes and their corresponding answers:

1. What is Enterobacter aerogenes?

Enterobacter aerogenes is a type of bacteria that belongs to the Enterobacteriaceae family. It is commonly found in the environment and can also colonize the human gastrointestinal tract. In healthcare settings, Enterobacter aerogenes is known for causing various infections, particularly in individuals with weakened immune systems.

2. How is Enterobacter aerogenes transmitted?

Enterobacter aerogenes can be transmitted through person-to-person contact, contaminated surfaces, or medical equipment. It is often spread in healthcare settings, such as hospitals, where there is a higher risk of infection due to the presence of vulnerable patients and frequent use of invasive procedures.

3. What are the symptoms of Enterobacter aerogenes infections?

The symptoms of Enterobacter aerogenes infections can vary depending on the site of infection. Common symptoms may include fever, chills, respiratory distress, urinary tract symptoms, wound infections, and bloodstream infections. It is important to note that some individuals may be asymptomatic carriers of Enterobacter aerogenes without showing any signs of infection.

4. Who is at risk of acquiring Enterobacter aerogenes?

Individuals with compromised immune systems, such as those with chronic illnesses, the elderly, and patients in intensive care units, are at a higher risk of acquiring Enterobacter aerogenes infections. Additionally, individuals who have undergone invasive procedures or received prolonged antibiotic treatment are also more susceptible to infection.

5. How is Enterobacter aerogenes diagnosed?

Diagnosing Enterobacter aerogenes infections typically involves collecting samples from the site of infection, such as blood, urine, or wound swabs. These samples are then analyzed in a laboratory to identify the presence of Enterobacter aerogenes and determine its antibiotic susceptibility profile.

6. What are the treatment options for Enterobacter aerogenes infections?

The choice of treatment for Enterobacter aerogenes infections depends on the severity of the infection and the antibiotic susceptibility of the bacteria. In many cases, a combination of antibiotics may be used to effectively treat the infection. However, it is important to note that Enterobacter aerogenes is becoming increasingly resistant to antibiotics, which poses challenges in treatment.

7. How can Enterobacter aerogenes infections be prevented?

Preventing Enterobacter aerogenes infections involves implementing strict infection control measures in healthcare settings. This includes proper hand hygiene, sterilization of medical equipment, adherence to infection prevention protocols, and judicious use of antibiotics. Additionally, promoting overall good health and immunity can also help reduce the risk of infection.

8. What is the impact of Enterobacter aerogenes on public health?

Enterobacter aerogenes, along with other hospital-acquired infections, poses a significant burden on public health. These infections can lead to increased morbidity, mortality, and healthcare costs. Furthermore, the emergence of antibiotic-resistant strains of Enterobacter aerogenes adds an additional layer of complexity in managing these infections.

9. What are the future perspectives on Enterobacter aerogenes?

Research efforts are focused on understanding the mechanisms of antibiotic resistance in Enterobacter aerogenes and developing new treatment strategies. Additionally, there is a growing emphasis on infection prevention and control measures to mitigate the spread of Enterobacter aerogenes and other healthcare-associated infections.

By staying informed about Enterobacter aerogenes and taking necessary precautions, healthcare providers and individuals can work together to minimize the impact of this hospital-acquired infection concern.